Thalocan Research Innovations team members Eric Zudak, Teresa DeHaemer and Tyler White are looking forward to an exciting few days at the Revolutionizing Atopic Dermatitis Conference (RAD 2026) in Nashville. This 3-day conference will focus exclusively on AD and the complex information that has accrued around proper diagnosis, treatment, and management. Our TRI team will…
Speaking the Same Language: Continuous Improvement at Every Level A conversation with Maggie Ellis, founder of Fluent Fox Language Solutions and a valued partner in Thalocan’s culture of continuous improvement. by Ginger Claremohr, Claremohr Writing Co. Long Before Brazil When Maggie Ellis traveled to Brazil, she described the experience as something that felt, in her…
Vitiligo Awareness Month, observed throughout June, is a global campaign dedicated to educating the public about the autoimmune disease, fighting social stigma, and supporting those living with the condition. All of us here at Thalocan Research Innovations applaud the work of the Vitiligo Research Foundation, among others so essential in spreading awareness and insight about…
June is Myasthenia Gravis (MG) Awareness Month. This annual campaign is designed to increase public understanding of this neuromuscular autoimmune disease, support those living with it, and raise funds for research. Here at Thalocan Research Innovations. we were proud to partner with Dr. Richard Barohn, Dr. Gil Wolfe and Instructor Laura Herbelin in creating Thalocan’s…
